Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy-
- CAS No.
- 2361659-61-0
- Chemical Name:
- Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy-
- Synonyms
- AES-135, 10 mM in DMSO;AES135,HDAC,HDAC3,HDAC11,pancreatic,HDAC6,anti-tumor,Inhibitor,AES 135,Histone deacetylases,inhibit,AES-135;Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy-
- CBNumber:
- CB85563085
- Molecular Formula:
- C33H29F6N3O5S
- Molecular Weight:
- 693.66
- MDL Number:
- MFCD31813798
- MOL File:
- 2361659-61-0.mol
| Product description | Number | Pack Size | Price |
| AES-135 98.31% | CS-0086984 | 5mg | $400 |
| AES-135 98.31% | CS-0086984 | 10mg | $680 |
| AES-135 98.31% | CS-0086984 | 25mg | $1350 |
| AES-135 98.31% | CS-0086984 | 50mg | $2200 |
| AES-135 98.31% | CS-0086984 | 100mg | $3400 |
Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy- price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0086984 | AES-135 98.31% | 2361659-61-0 | 5mg | $400 | 2021-12-16 | Buy |
| ChemScene | CS-0086984 | AES-135 98.31% | 2361659-61-0 | 10mg | $680 | 2021-12-16 | Buy |
| ChemScene | CS-0086984 | AES-135 98.31% | 2361659-61-0 | 25mg | $1350 | 2021-12-16 | Buy |
| ChemScene | CS-0086984 | AES-135 98.31% | 2361659-61-0 | 50mg | $2200 | 2021-12-16 | Buy |
| ChemScene | CS-0086984 | AES-135 98.31% | 2361659-61-0 | 100mg | $3400 | 2021-12-16 | Buy |
Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy- Chemical Properties,Uses,Production
Uses
AES-135, a hydroxamic acid-based pan-HDAC inhibitor, prolongs survival in an orthotopic mouse model of pancreatic cancer. AES-135 inhibits HDAC3, HDAC6, HDAC8, and HDAC11 with IC50s ranging from 190-1100 nM[1].
in vivo
AES-135 (50 mg/kg; intraperitoneal injection; 5 days a week; for 1 month) treatment significantly increases survival of C57Bl/6 mice implanted with KPC2 cells[1].
NSG mice are dosed with a single 20 mg/kg intraperitoneal (IP) injection, and blood is taken at 0.5 h, 1 h, 2 h, 4 h, 8 h, and 24 h. AES-135 achieved μM concentrations in the blood, reaching Cmax 7452 ng/mL (10.74 μM) within 30 min, which is sustained for 8 h. The blood concentration of AES-135 is dose dependent, achieving an average of 323 ng/mL (0.47 μM) with 10 mg/kg dosing and 1829 ng/mL (2.64 μM) with 40 mg/kg. AES-135 shows an impressive pharmacokinetic profile in mice with an in vivo half-life of 5.0 h[1].
| Animal Model: | C57Bl/6 mice injected with KPC2 cells[1] |
| Dosage: | 50 mg/kg |
| Administration: | Intraperitoneal injection; 5 days a week; for 1 month |
| Result: | Significantly increased survival of mice. |
IC 50
HDAC6: 190 nM (IC50); HDAC11: 636 nM (IC50); HDAC3: 654 nM (IC50); HDAC8: 1100 nM (IC50)
References
[1] Shouksmith AE, et al. Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer. J Med Chem. 2019 Mar 14;62(5):2651-2665. DOI:10.1021/acs.jmedchem.8b01957
Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy- Preparation Products And Raw materials
Raw materials
Preparation Products
Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy- Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32435 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 39035 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 52923 | 58 | |
| TargetMol Chemicals Inc. | +17819995354 | marketing@targetmol.com | United States | 19961 | 58 |
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 12952 | 65 |
| Shanghai Beckham Medical Technology Co., Ltd | 13816613772 | huahero21@sina.com | China | 2391 | 55 |
| Hangzhou ChangCun Biotechnology Co., Ltd. | 0571-; 13567100326 | 158848739@qq.com | China | 108 | 50 |
| Fan De(Beijing) Biotechnology Co., Ltd. | 15911056312 | liming@bio-fount.com | China | 9729 | 58 |
| Chengdu Peter-like Biotechnology Co., Ltd. | 18108052721 | 2850505130@qq.com | China | 5167 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 15801484223; | psaitong@jm-bio.com | China | 29757 | 58 |
View Lastest Price from Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy- manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2025-12-09 | AES-135
2361659-61-0
|
US $76.00-278.00 / mg | 98.01% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-12-09 | AES-135
2361659-61-0
|
US $76.00-278.00 / mg | 98.01% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-05-17 | AES-135
2361659-61-0
|
US $76.00-278.00 / mg | 98.01% | 10g | TargetMol Chemicals Inc. |







